Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

20/25/20	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/25/17	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	27.07L 23.38L 21.55L 20.17L 37.8L 26Cr 38.38L 2.54Cr 99.19L 13Cr 1.02Cr 99.43L 43Cr	P/E Ratio 2022	-0.25x	P/E Ratio 2023	-0.19x
Enterprise Value	1.28Cr 1.11Cr 1.02Cr 95.56L 1.79Cr 121.92Cr 1.82Cr 12Cr 4.7Cr 59Cr 4.81Cr 4.71Cr 205.48Cr	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

20/25/20	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
17/25/17	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
11/25/11	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
11/25/11	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
11/25/11	Avinger, Inc. Announces Executive Changes	CI
24/24/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/24/24	US Futures Tread Water Ahead of Holiday Break	MT
24/24/24	Iberdrola Completes Merger with Avangrid	MT
08/24/08	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
08/24/08	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
08/24/08	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
08/24/08	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/24/04	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

21/23/21	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/22/11	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/22/18	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/21/29	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

02/25/02	Avinger : Private Placement Form 8 K	PU
08/24/08	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/24/08	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
08/24/08	Avinger: Q3 Earnings Snapshot	AQ
25/24/25	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

AVINGER Share Price Nasdaq

Stocks

Advanced Medical Equipment & Technology

Valuation: AVINGER

Latest news : AVINGER

Analysts' recommendations: AVINGER

Press Releases: AVINGER

Managers and Directors: AVINGER

Medical Imaging Systems

Financials

Company Profile

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	05/08/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	+1.60%	+0.92%	-11.95%	-16.85%	1.38TCr
IRAY GROUP	-5.68%	-9.58%	+76.48%	+11.82%	489.3Cr
SONOSCAPE MEDICAL CORP.	+3.68%	-1.60%	-38.95%	-64.79%	125.47Cr
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+1.85%	-6.01%	-33.54%	-43.06%	120.21Cr
IRADIMED CORPORATION	-2.76%	+0.57%	+60.91%	+90.24%	119.65Cr
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	+5.99%	-0.89%	-40.57%	-	98Cr
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	+0.47%	-5.38%	+192.61%	+183.63%	72Cr
CAPSOVISION, INC.	+4.35%	0.00%	-	-	36Cr
FISCHER MEDICAL VENTURES LIMITED	-1.30%	+11.03%	-59.11%	+207.35%	25Cr
Average	+0.91%	+0.32%	+18.23%	+52.62%	274.12Cr
Weighted average by Cap.	+0.22%	-1.25%	+11.36%	-0.74%

	2022	2023
Net sales	82.73L 71.45L 65.84L 61.63L 1.16Cr 79Cr 1.17Cr 7.77Cr 3.03Cr 38Cr 3.1Cr 3.04Cr 132.53Cr	76.52L 66.09L 60.9L 57.01L 1.07Cr 73Cr 1.08Cr 7.19Cr 2.8Cr 35Cr 2.87Cr 2.81Cr 122.58Cr
Net income	-1.76Cr -1.52Cr -1.4Cr -1.31Cr -2.46Cr -167.51Cr -2.5Cr -17Cr -6.46Cr -82Cr -6.61Cr -6.47Cr -282.3Cr	-1.83Cr -1.58Cr -1.46Cr -1.36Cr -2.56Cr -174.13Cr -2.6Cr -17Cr -6.71Cr -85Cr -6.88Cr -6.73Cr -293.47Cr
Net Debt	17.56L 15.17L 13.98L 13.08L 24.52L 17Cr 24.9L 1.65Cr 64.34L 8.12Cr 65.9L 64.5L 28Cr	1.01Cr 87.41L 80.55L 75.39L 1.41Cr 96Cr 1.43Cr 9.51Cr 3.71Cr 47Cr 3.8Cr 3.72Cr 162.11Cr

End-of-day quote Nasdaq Other stock markets
- ^USD	-